Figures 2a, c, e, and g show the percentage of individuals presenting with anxiety, apathy, motor disturbances, or appetite/eating disturbances (statistically significant in model 1) according to their Aβ, p-tau, and LB pathology status at baseline. This evidence concerns the gene MAPT and Anxiety.